Amedisys (AMED) Cash Flow Statement

Click line-items for a historical chart and %

Net income	28.66M
Depreciation and amortization
Provision for doubtful accounts	13.66M
Non-cash compensation	12.56M
401(k) employer match
Loss on disposal of property and equipment	556K
Deferred income taxes	18.69M
Equity in earnings of unconsolidated joint ventures	-3.6M
Amortization of deferred debt issuance costs	555K
Return on equity investment	1.91M
Patient accounts receivable	-46.11M
Other current assets	870K
Other assets	-11.91M
Accounts payable	7.31M
Accrued expenses	-9.1M
Other long-term obligations
Net cash provided by operating activities	33.7M
Proceeds from sale of deferred compensation plan assets	230K
Purchases of deferred compensation plan assets	0
Purchases of property and equipment	-13.5M
Acquisitions of businesses, net of cash acquired	-31.38M
Acquisitions of reacquired franchise rights
Net cash used in investing activities	-45.4M
Proceeds from issuance of stock upon exercise of stock options and warrants	0
Proceeds from issuance of stock to employee stock purchase plan	1.82M
Tax benefit from stock option exercises	7.24M
Non-controlling interest distribution
Principal payments of long-term obligations	-3.75M
Net cash used in financing activities	-6.89M
Net (decrease) increase in cash and cash equivalents	-18.59M
Cash and cash equivalents at beginning of period	27.5M
Cash and cash equivalents at end of period	8.92M
Cash paid for interest	2.28M
Cash paid for income taxes, net of refunds received	758K
Notes payable issued for acquisitions
Notes payable issued for software licenses

Entities mentioned with AMED

View All Entities